Tesla Stock Slides Amid Broad Renewable Energy Sell-Off: What’s Going On?
Tesla shares are trading lower by around 4% Tuesday afternoon. The stock is down amid a broader market pullback in renewable energy stocks. read more
Read More
FDA Introduces Tumor Board-Style Reviews For Faster Drug Decisions
FDA unveils a priority voucher program to accelerate drug reviews for national priorities, using a team-based review model. read more
Amazon CEO Says Generative AI Will Reduce Total Corporate Workforce
Amazon CEO Andy Jassy highlights company’s extensive use of Generative AI to drive value, citing its rare transformative capabilities. read more
FrontView REIT A ‘Special Situation’ With Increased Takeover Potential Post-CFO Ousting: Analyst
FrontView downgraded as analyst sees limited growth, CFO turmoil, and rising M&A potential amid deep valuation discount. read more
RedWire Shares Are Down Today: What’s Going On?
Redwire Corporation (NYSE: RDW shares are trading higher Tuesday after the company announced the pricing of a major public stock offering. read more
These Analysts Revise Their Forecasts On Sage Therapeutics Following Acquisition News
Latest Ratings for SUPN Date Firm Action From To Apr 2021 Jefferies Upgrades Hold Buy Jun 2020 Piper Sandler Upgrades Neutral Overweight Jun 2020 Jefferies Reinstates Hold View More Analyst Ratings for SUPN View the Latest Analyst Ratings read more
Beyond Magnificent 7: Can Thematic ETFs Like IVES Lead The Next Wave Of AI Investing? CIO Cullen Rogers Explains
Wedbush Fund Advisers CIO Cullen Rogers tells Benzinga: “We don’t react to short-term performance or headlines.” read more
Gilead’s HIV Prevention Drug Could Be Manufactured At Shocking Low Cost: Report
Lenacapavir, a twice-yearly HIV prevention shot by Gilead, could be produced for $25 a year but may sell for $25K, raising concerns over global access and equity. read more
What’s Going On With Digital Turbine Shares Today?
Shares of Digital Turbine Inc. (NASDAQ: APPS) are trading higher Tuesday after the company released its fourth-quarter financial results that exceeded analyst expectations. read more